Staphylococcus aureus leukotoxin GH promotes inflammation

Journal of Infectious Diseases

Volumn 206, Issue 8, 2012, Pages 1185-1193

  Malachowa, Natalia ^a   Kobayashi, Scott D ^a   Braughton, Kevin R ^a   Whitney, Adeline R ^a   Parnell, Michael J ^a   Gardner, Donald J ^a   Deleo, Frank R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTOXIN; LEUKOTOXIN GH; PANTON VALENTINE LEUKOCIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL SKIN DISEASE; BACTERIAL STRAIN; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DRUG CYTOTOXICITY; HAPLORHINI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; DISEASE MODELS, ANIMAL; EXOTOXINS; HUMANS; INFLAMMATION; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; MACACA FASCICULARIS; MALE; MICE; NEUTROPHILS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84866904087     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis495     Document Type: Article

References (28)

1. DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 2009; 23:17-34.
2. Prevost G, Cribier B, Couppie P, et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 1995; 63:4121-9.
3. Ventura CL, Malachowa N, Hammer CH, et al. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PloS One 2010; 5:e11634.
4. Menestrina G, Dalla Serra M, Comai M, et al. Ion channels and bacterial infection: the case of β-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Lett 2003; 552:54-60. (Pubitemid 37103009)
5. Jayasinghe L, Bayley H. The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis. Protein Sci 2005; 14:2550-61. (Pubitemid 41395582)
6. Dumont AL, Nygaard TK, Watkins RL, et al. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 2011; 79:814-25.
7. Voyich Jovanka M, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-70. (Pubitemid 44902009)
8. Malachowa N, Whitney AR, Kobayashi SD, et al. Global changes in Staphylococcus aureus gene expression in human blood. PloS One 2011; 6:e18617.
9. Graves SF, Kobayashi SD, Braughton KR, et al. Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants. Microbes Infect 2010; 12:446-56.
10. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci USA 2002; 99:6901-6. (Pubitemid 34526230)
11. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-19. (Pubitemid 41292051)
12. Siemsen DW, Schepetkin IA, Kirpotina LN, Lei B, Quinn MT. Neutrophil isolation from nonhuman species. Methods Mol Biol 2007; 412:21-34.
13. Kobayashi SD, Malachowa N, Whitney AR, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011; 204:937-41.
14. Kennedy AD, Wardenburg JB, Gardner DJ, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 2010; 202:1050-8.
15. Loffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010; 6:e1000715.
16. Cribier B, Prevost G, Couppie P, Finck-Barbancon V, Grosshans E, Piemont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? Dermatology 1992; 185:175-80.
17. Siqueira JA, Speeg-Schatz C, Freitas FIS, Sahel J, Monteil H, Prevost G. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J Med Microbiol 1997; 46:486-94. (Pubitemid 27242577)
18. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010; 107:5587-92.
19. Graves SF, Kobayashi SD, Braughton KR, et al. Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol 2012; 92:361-74.
20. Alonzo F 3rd, Benson MA, Chen J, Novick RP, Shopsin B, Torres VJ. Staphylococcus aureus leukocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol 2011; 83:423-35.
21. Panton PN, Valentine FCO. Staphylococcal toxin. Lancet 1932; 219:506-8.
22. Woodin AM. Staphylococcal leukocidin. In: Montje T, Kadis S, Ajl S, eds. Microbial toxins. New York and London: Academic Press, Inc., 1970:327-55.
23. Yoong P, Pier GB. Antibody-mediated enhancement of communityacquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci USA 2010; 107:2241-6.
24. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind ODeLeo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillinresistant Staphylococcus aureus disease. J Infect Dis 2008; 198: 1166-70.
25. Bae IG, Tonthat GT, Stryjewski ME, et al. Presence of genes encoding the Panton-Valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009; 47:3952-7.
26. König B, Prévost G, Piémont Y, König W. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995; 171:607-13.
27. Hensler T, König B, Prévost G, Piémont Y, Köller M, König W. Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocytemacrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun 1994; 62:2529-35.
28. Colin DA, Monteil H. Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 2003; 71:3724-9. (Pubitemid 36753692)